NCT04519749 An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04455230 A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190 Status COMPLETED Phase PHASE1/PHASE2
NCT04281537 A Study to Describe the Experience of Both Patients and Their Clinicians in the Treatment of Fabry Disease With Enzyme Replacement Therapy. Status COMPLETED Phase N/A
NCT04252066 A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding Status RECRUITING Phase N/A
NCT04143958 To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry Disease Status WITHDRAWN Phase PHASE4
NCT04073888 Study of the Spermatic Characteristics of Patients With Fabry Disease Status COMPLETED Phase NA
NCT04049760 Safety, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged >12 Years) With Fabry Disease Status COMPLETED Phase PHASE3
NCT04046224 Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR) Status COMPLETED Phase PHASE1/PHASE2
NCT04043273 Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences Status COMPLETED Phase N/A
NCT04025801 Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals Status UNKNOWN Phase N/A
NCT04020055 A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03737214 A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3